查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1847812

乳房切片市场按技术、手术类型和最终用户划分 - 全球预测 2025-2032

Breast Biopsy Market by Technology, Procedure Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，乳房切片市场规模将达到 22.7 亿美元，复合年增长率为 9.55%。

主要市场统计数据
基准年 2024 10.9亿美元
预计年份：2025年 12亿美元
预测年份：2032年 22.7亿美元
复合年增长率 (%) 9.55%

建构以病人为中心的乳房切片综合观点，将临床结果、器材创新和机构策略结合

乳房疾病的诊断依赖于及时、准确且微创的组织取样。影像学和仪器技术的进步丰富了临床医生可选择的切片检查方式，而患者对安全性和舒适度的期望也正在改变手术流程的优先顺序。因此，医疗决策者、製造商和临床团队必须在多种医疗环境中，平衡日益增长的精准度需求与实际操作限制。

本出版物透过概述技术、临床实践和医疗保健系统交付之间不断演变的相互关係，建构了一个更深层的分析框架。它重点强调了对手术个体化、跨部门协作和数据主导的品质保证日益增长的重视。此外，它还着重阐述了监管机构对器械安全性和疗效比较的关注如何重塑产品开发週期和应用管道。接下来的章节将从临床结果、效率和病人体验的角度出发，探讨这个主题对价值链上相关人员的策略意义。

影像技术的进步、设备的模组化以及以患者为中心的服务模式如何重塑乳房切片护理的临床工作流程和采购重点

乳房切片领域正经历显着的变革，这主要得益于技术小型化、影像技术的整合以及对以患者为中心的工作流程的重新重视。高解析度超音波和先进的磁振造影序列等显像模式正变得越来越普及和易于互操作，使临床医生能够更精准地定位病灶并缩短手术时间。同时，设备製造商也朝着模组化设计方向发展，优先考虑人体工学、即时回馈以及与多种成像平台的兼容性。

这种转变也体现在医疗服务模式中。由于效率和便利性，门诊和流动医疗机构越来越多地进行以往仅在住院机构进行的复杂诊断程序。同时，临床路径强调共同共用，并要求就切片检查的风险、益处和预期诊断价值进行更清晰的沟通。总而言之，这些趋势正在重塑采购重点、操作人员培训要求和供应商合作模式，为愿意适应的相关人员创造新的机会和竞争压力。

评估2025年关税调整的影响，以及相关人员如何调整其采购策略，进而影响下游营运和供应链。

改变医疗设备采购和临床报销经济模式的政策措施可能会对整个供应链和医疗保健系统产生连锁反应。 2025年实施的关税调整带来了成本压力，影响了采购决策、定价策略和库存管理的地理布局。采购团队的因应措施包括重新评估供应商多样性、优化物流以及寻求合约保护以降低跨境关税波动带来的风险。

同时，製造商评估了製造地和售后支援模式，以确保利润率并确保供应的连续性。在这些调整过程中，合规性和品质保证仍然是重中之重，促使製造商加强对国内组装和高效分销管道的投资。临床医生和医疗系统领导者透过重新审视病例组合和排班模式来适应变化，从而在不影响医疗服务可及性的前提下消化单位成本的上涨。最后，关税环境凸显了灵活的筹资策略和积极的商业规划对于在不断变化的贸易环境中维持服务水准的重要性。

透过对设备技术、手术方式和最终用户环境进行详细的細項分析，提供有针对性的商业化和临床应用策略。

细分市场洞察揭示了因技术、手术类型和终端用户环境而异的细微需求驱动因素，因此需要差异化的商业和临床策略。按技术粗针穿刺切片设备在手术选择中占据重要份额，并提供自动化和半自动化配置，以平衡通量和操作者控制。细针穿刺针包括适用于细胞学工作流程的标准针头，以及用于超音波视觉化效果的迴声增强型针头。真空辅助系统分为两类：一类是专为照护现场主导而优化的手持式设备，另一类是专为复杂病灶和高流量环境而设计的桌上型平台。

对手术类型进行细分，有助于更清晰地确定设备选择和培训的优先顺序。 MRI导引手术根据封闭式和开放式系统进行区分，每种系统都需要考虑病灶的可见性和患者的耐受性。触诊导引手术仍然是可行的选择，包括徒手触诊和在影像访问受限时使用的网格导引手术。立体定位切片检查可在俯卧和直立位下进行，这会影响患者体位、成像几何形状和手术时间。超音波引导介入手术因二维和新兴的三维成像技术而异，这会影响靶向精度和操作者的学习曲线。最后，最终用户细分揭示了需求集中在哪里以及采购和运营标准有何不同：门诊手术中心（包括诊断中心和门诊手术中心）优先考虑的是每次手术的吞吐量和成本效益；私立和公立医院强调的是全面的服务组合和强大的库存支持；而专科诊所（例如肿瘤科和放射科诊所）则强调临床专业知识、综合诊断和患者导航。这些细分揭示了创新、服务模式和商业性合作将在哪些方面产生最大的策略影响。

美洲、中东和非洲以及亚太地区的区域动态和策略考虑将影响招募、分销和临床支援优先事项。

区域动态影响临床实践模式和商业性需求，而从地理角度出发的细緻观点有助于相关人员优先考虑市场准入、分销和支持性投资。在美洲，医疗系统强调以价值为导向的医疗服务、提高手术效率和扩大门诊病人服务，从而催生了对易于使用的设备和整合工作流程解决方案的需求。该地区的报销机制和医院采购流程往往倾向于选择已证实具有临床疗效和完善的上市后支援的产品。

欧洲、中东和非洲地区管理体制的多样性和基础设施的差异，造就了机会与挑战并存的局面。该地区部分市场正迅速采用先进的影像和设备平台，而其他市场则优先考虑成本效益高、可扩展的解决方案，以便应用于各种医疗环境。在地化生产、监管协调和培训伙伴关係往往是胜利的关键因素。在亚太地区，医院的快速现代化和筛检计画的增加推动了对精准切片检查解决方案的需求，而市场参与企业必须应对当地的监管管道、分销网络以及临床医生培训需求，才能实现持续的市场应用。了解这些区域特征，有助于製造商和医疗系统规划者调整产品系列、商业模式和支援服务，从而最大限度地提高临床和营运的相关性。

竞争格局和企业层面的策略讯号强调透过整合解决方案、临床伙伴关係和卓越服务实现差异化。

乳房切片生态系统的竞争动态以技术差异化、服务主导的价值提案和策略协同为特征。领先的设备开发人员正日益将硬体与数位化工具相结合，以增强手术规划、文件记录和术后追踪。因此，能够提供涵盖设备可靠性、影像互通性和资料整合等端到端解决方案的公司，更有利于建立长期的合作关係。

设备製造商、影像供应商和临床中心之间的伙伴关係能够加速创新週期，并支援临床检验工作流程的开发。此外，供应链的韧性、对监管的应对力以及卓越的服务是医院系统和专科诊所的关键考虑因素。新参与企业往往透过专注于人体工学设计和一次性组件等细分领域的创新来获得初期发展动力，而参与企业则利用其规模、全球分销和临床证据来巩固市场地位。最终，在竞争格局中，那些投资于临床医生培训、市场研究和基于结果的有效证据的机构将获得回报。

为製造商和医疗系统提供切实可行的策略指南，以协调创新、赋能和供应链韧性，从而加速产品应用和价值实现。

行业领导者应采取平衡策略，将产品创新、营运支援和临床医生赋能相结合，以加速产品普及并保持价值。首先，优先考虑能够提升操作人体工学和影像相容性，同时降低设定复杂性的设备设计。其次，投资临床医生教育计画和基于模拟的培训，以提高操作一致性并支持品质指标。第三，拓展服务范围，使其超越硬体本身，涵盖操作流程咨询、远端故障排除和结果追踪工具，从而建立更牢固的客户关係。

此外，应拓展供应链选择，将本地组装与战略库存中心结合，以降低关税和物流相关的干扰。与影像供应商和专科诊所合作，检验整合工作流程，并创建能够引起支付方和采购委员会共鸣的真实案例。最后，采用灵活的商业模式，从按次计费的耗材定价到捆绑式解决方案合同，以满足不同客户的预算需求，并加速在门诊、住院和专科护理机构的推广应用。这些措施相结合，能够帮助机构将创新转化为可衡量的临床和商业性效益。

结合文献综述、临床医师访谈和资料三角验证的多源资讯来源调查方法，检验策略性见解并减少分析限制。

我们的调查方法以结构化和透明的方式综合证据，旨在确保分析的严谨性和实际应用价值。此方法首先对同行评审的临床文献、监管文件和器械技术文件进行全面审查，以建立对安全性、手术适应症和器械特性的基本了解。随后进行定性研究，包括对介入放射科医生、乳房外科医生、采购负责人和器械工程师的访谈，以揭示实际应用中的驱动因素、障碍和未满足的需求。

资料三角验证确保了主要来源和次要来源之间的一致性，与临床顾问举行的检验研讨会完善了解读并确定了策略意义的优先顺序。调查方法方法包括设备功能比较映射、流程路径分析和供应链风险评估。研究指出了方法学上的局限性，例如实践模式的区域差异和不断发展的影像技术，并描述了相应的缓解措施，包括专家选择性抽样和敏感性检定。伦理方面的考量包括保密性、所有访谈均需获得知情同意，以及对从业人员资料进行匿名化处理以保护专家隐私。

整合策略要务，阐明临床证据、商业敏捷性和营运韧性如何决定乳房切片护理的长期成功

临床趋势、技术进步和营运实际情况的综合表明，近期面临的挑战在于，精准度、患者体验和供应链韧性这三者相互交织，成为成功的关键决定因素。如果能够提供强有力的培训和服务支持，那么在目标精准度、人体工学和与影像系统互通性方面具有显着改进的设备很可能获得临床认可。同时，医疗系统将继续优先考虑手术量和成本控制，从而催生对可在门诊和住院环境中部署的模组化解决方案的需求。

总之，整合临床证据产生、灵活商业模式和稳健供应链策略的相关人员将更有利于创造价值并改善病患疗效。随着这一格局的演变，与临床医生持续互动、大力投资上市后证据以及製定适应性强的商业计划，对于保持发展势头并将创新转化为日常实践仍然至关重要。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 整合人工智慧和深度学习技术，提高切片检查靶向的准确性和效率
  • 采用微创真空辅助切片检查系统，以提高患者舒适度并缩短手术时间
  • 增加造影增强数位乳房断层合成导引切片检查的使用，以提高病灶视觉化效果和样本采集准确性
  • 新兴的液态生物检体技术可与全面的分子分析和组织取样相结合，用于早期检测。
  • 开发可携式即时检测设备，以实现分散式诊断和快速临床决策。
  • 引入即时离体共聚焦显微镜，可实现即时组织评估并降低重复活检率
  • 扩展的机器人辅助乳房切片平台提高了手术的一致性，并减少了操作者之间的差异。
  • 不断变化的医保报销政策和法规结构正在推动全球先进乳房切片技术的普及。

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

第八章乳房切片市场（依技术划分）

  • 核心针切片装置
    • 自动穿刺切片装置
    • 半自动穿刺切片装置
  • 细针吸针
    • 超音波增强细针穿刺
    • 标准细针穿刺针
  • 真空辅助系统
    • 手持真空辅助
    • 工作台配置真空辅助

第九章 依手术类型分類的乳房切片市场

  • MRI 指南
    • 封闭式
    • 开膛式
  • 触诊指南
    • 徒手触诊
    • 网格指南
  • 切片检查定位活检
    • 俯卧立体定位放射治疗
    • 直立姿势
  • 超音波引导
    • 二维超音波引导
    • 三维超音波引导

第十章乳房切片市场（按最终用户划分）

  • 门诊病人手术中心
    • 诊断中心
    • 门诊手术中心
  • 医院
    • 私立医院
    • 公立医院
  • 专科诊所
    • 肿瘤诊所
    • 放射科诊所

第十一章 各地区乳房切片市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章乳房切片市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章 各国乳房切片市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Hologic, Inc.
    • Becton Dickinson and Company
    • General Electric Company
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Cook Medical, Inc.
    • Merit Medical Systems, Inc.
    • Cardinal Health, Inc.
    • Medtronic plc
Product Code: MRR-4F4C36263235

The Breast Biopsy Market is projected to grow by USD 2.27 billion at a CAGR of 9.55% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.09 billion
Estimated Year [2025] USD 1.20 billion
Forecast Year [2032] USD 2.27 billion
CAGR (%) 9.55%

Setting the stage for an integrated and patient-centered view of breast biopsy care that connects clinical outcomes, device innovation, and institutional strategy

The diagnostic pathway for breast disease hinges on timely, accurate, and minimally invasive tissue sampling. Advances in imaging and device engineering have diversified the array of biopsy options available to clinicians, while patient expectations for safety and comfort have shifted procedural priorities. Consequently, institutional decision-makers, manufacturers, and clinical teams must reconcile rising demand for precision with operational constraints in multiple care settings.

This introduction establishes the context for deeper analysis by outlining the evolving intersections of technology, clinical practice, and health system delivery. It highlights the growing emphasis on procedure personalization, cross-disciplinary collaboration, and data-driven quality assurance. Moreover, it underscores how regulatory emphasis on device safety and comparative effectiveness is reshaping product development cycles and adoption pathways. By framing the topic in terms of clinical outcomes, throughput, and patient experience, the subsequent sections will explore the strategic implications for stakeholders across the value chain.

How converging imaging advances, device modularity, and patient-centered delivery models are reshaping clinical workflows and procurement priorities in breast biopsy care

The landscape for breast biopsy is undergoing transformative shifts driven by technological miniaturization, imaging convergence, and a renewed focus on patient-centric workflows. Imaging modalities such as high-resolution ultrasound and advanced MRI sequences have become more accessible and interoperable, enabling clinicians to target lesions with greater accuracy and reduced procedure time. At the same time, device manufacturers have converged on modular designs that prioritize ergonomics, real-time feedback, and compatibility with multiple imaging platforms.

These shifts are also reflected in care delivery models: outpatient and ambulatory environments increasingly perform diagnostically complex procedures previously restricted to inpatient settings, driven by efficiency and patient convenience. Meanwhile, clinical pathways emphasize shared decision-making, which requires clearer communication of biopsy risks, benefits, and expected diagnostic value. Taken together, these trends are rewriting procurement priorities, operator training requirements, and vendor collaborations, creating new opportunities and competitive pressures for stakeholders prepared to adapt.

Assessing the downstream operational and supply chain consequences of tariff adjustments during 2025 and how stakeholders realigned sourcing and procurement strategies

Policy instruments that alter the economic calculus of device procurement and clinical reimbursement can produce ripple effects throughout the supply chain and care continuum. Tariff adjustments implemented in 2025 introduced discrete cost pressures that influenced sourcing decisions, pricing strategies, and the geographic orientation of inventory management. Procurement teams responded by reassessing supplier diversity, optimizing logistics, and seeking contractual protections that mitigate exposure to cross-border tariff volatility.

In parallel, manufacturers evaluated their manufacturing footprints and aftermarket support models to preserve margin and ensure continuity of supply. Regulatory compliance and quality assurance remained top priorities during these adjustments, prompting incremental investments in domestic assembly and validated distribution channels. Clinicians and health system leaders adapted by reexamining case mix and scheduling patterns to absorb incremental unit costs without compromising access. Ultimately, the tariff environment underscored the importance of flexible sourcing strategies and proactive commercial planning to sustain service levels amid shifting trade conditions.

Detailed segmentation analysis across device technologies, procedural modalities, and end-user settings to inform targeted commercialization and clinical adoption strategies

Segmentation insights reveal nuanced demand drivers that vary across technology, procedure type, and end-user settings and therefore require differentiated commercial and clinical strategies. Within technology, Core Needle Biopsy Devices account for a substantial portion of procedural choices and are available in automated and semi-automated configurations that balance throughput with operator control. Fine Needle Aspiration Needles include echo-enhanced variants for improved sonographic visualization alongside standard needles that remain relevant for cytology-driven workflows. Vacuum-Assisted Systems present a bifurcated product set with handheld devices optimized for point-of-care convenience and table-configured platforms designed for complex lesion access and high-volume environments.

Procedure-type segmentation further informs device selection and training priorities. MRI-guided approaches are differentiated by closed-bore and open-bore systems, each aligning with specific lesion visibility and patient tolerance considerations. Palpation-guided procedures persist as pragmatic options through freehand palpation and grid-guided techniques where imaging access is limited. Stereotactic biopsies comprise prone and upright configurations, which influence patient positioning, imaging geometry, and procedure time. Ultrasound-guided interventions vary between 2D and emerging 3D imaging capabilities, which affect targeting precision and operator learning curves. Finally, end-user segmentation clarifies where demand concentrates and how procurement and operational criteria diverge: Ambulatory Surgery Centers, including diagnostic centers and outpatient surgery centers, prioritize throughput and per-procedure cost-efficiency; Hospitals, spanning private and public institutions, emphasize comprehensive service portfolios and robust inventory support; Specialty Clinics, such as oncology and radiology clinics, focus on clinical specialization, integrated diagnostics, and patient navigation. Together, these segmentation lenses illuminate where innovation, service models, and commercial engagement will have the highest strategic impact.

Regional dynamics and strategic considerations across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence adoption, distribution, and clinical support priorities

Regional dynamics shape both clinical practice patterns and commercial imperatives, and a geographically nuanced view helps stakeholders prioritize market entry, distribution, and support investments. In the Americas, health systems emphasize value-based care, procedural efficiency, and outpatient expansion, creating demand for user-friendly devices and integrated workflow solutions. Reimbursement mechanisms and hospital procurement processes in this region tend to favor demonstrable clinical benefit and robust post-market support.

In Europe, Middle East & Africa, diverse regulatory regimes and heterogeneous infrastructure create a mosaic of opportunity and constraint. Some markets in this region adopt advanced imaging and device platforms rapidly, while others prioritize cost-effective, scalable solutions that can be deployed across variable care settings. Local manufacturing, regulatory harmonization, and training partnerships often become differentiators. Asia-Pacific presents a broad spectrum of adoption trajectories where rapid hospital modernization and rising screening programs drive demand for precision biopsy solutions; meanwhile, market entrants must navigate local regulatory pathways, distribution networks, and clinician training needs to realize sustainable uptake. Understanding these regional contours allows manufacturers and health system planners to tailor product portfolios, commercial models, and support services for maximal clinical and operational relevance.

Competitive landscape and company-level strategic signals highlighting differentiation through integrated solutions, clinical partnerships, and service excellence

Competitive dynamics in the breast biopsy ecosystem are characterized by technology differentiation, service-led value propositions, and strategic collaboration. Leading device developers increasingly couple hardware offerings with digital tools that enhance procedural planning, documentation, and post-procedure tracking. As a result, companies that can demonstrate end-to-end solutions-combining device reliability, imaging interoperability, and data integration-are better positioned to secure long-term institutional relationships.

Partnerships between device manufacturers, imaging vendors, and clinical centers accelerate innovation cycles and support the development of clinically validated workflows. Moreover, supply chain resilience, regulatory responsiveness, and service excellence serve as critical decision criteria for hospital systems and specialty clinics. New entrants tend to focus on niche innovations-such as ergonomic designs or disposable components-to gain initial traction, while established players leverage scale, global distribution networks, and clinical evidence to defend market positions. Ultimately, the competitive landscape rewards organizations that invest in clinician training, post-market surveillance, and meaningful outcome-based evidence.

Actionable strategic playbook for manufacturers and health systems to align innovation, enablement, and supply chain resilience to accelerate adoption and value realization

Industry leaders should pursue a balanced strategy that aligns product innovation with operational support and clinician enablement to accelerate adoption and sustain value. First, prioritize device designs that enhance procedural ergonomics and imaging compatibility while reducing setup complexity; this approach shortens learning curves and improves throughput. Second, invest in clinician education programs and simulation-based training that reinforce technique consistency and support quality metrics. Third, expand service offerings beyond hardware to include procedural workflow consulting, remote troubleshooting, and outcome-tracking tools that create stickier customer relationships.

Furthermore, diversify supply chain options to mitigate tariff and logistics-related disruptions by combining localized assembly with strategic inventory hubs. Forge partnerships with imaging vendors and specialty clinics to validate integrated workflows and produce real-world evidence that resonates with payers and procurement committees. Lastly, adopt flexible commercial models-ranging from per-procedure consumable pricing to bundled solution contracts-to accommodate diverse customer budgets and accelerate adoption across ambulatory, hospital, and specialty settings. These combined actions will help organizations translate innovation into measurable clinical and commercial gains.

Robust, multi-source research methodology combining literature synthesis, clinician interviews, and data triangulation to validate strategic insights and mitigate analytical limitations

This research synthesizes evidence from a structured and transparent methodology designed to ensure analytical rigor and practical relevance. The approach began with a comprehensive review of peer-reviewed clinical literature, regulatory filings, and technical device documentation to establish a baseline understanding of safety profiles, procedural indications, and device characteristics. Next, qualitative primary research included interviews with practicing interventional radiologists, breast surgeons, procurement leaders, and device engineers to surface real-world adoption drivers, barriers, and unmet needs.

Data triangulation ensured consistency between primary insights and secondary sources, and validation workshops with clinical advisors refined interpretations and prioritized strategic implications. Analytical methods included comparative device feature mapping, procedural pathway analysis, and supply chain risk assessment. The research also documents methodological limitations, such as variability in practice patterns across regions and the evolving nature of imaging technology, and describes mitigation strategies like purposive sampling of experts and sensitivity checks. Ethical considerations governed confidentiality, informed consent for all interviews, and anonymization of practitioner-level data to preserve professional privacy.

Synthesis of strategic imperatives showing how clinical evidence, commercialization agility, and operational resilience will determine long-term success in breast biopsy care

The synthesis of clinical trends, technological progress, and operational realities points to a near-term agenda where precision, patient experience, and supply chain resilience intersect as primary determinants of success. Devices that offer clear improvements in targeting accuracy, ergonomics, and interoperability with imaging systems will find receptive clinical audiences when supported by robust training and service commitments. Meanwhile, health systems will continue to emphasize procedural throughput and cost control, creating demand for modular solutions that can be deployed across ambulatory and hospital settings.

In summary, stakeholders that integrate clinical evidence generation, flexible commercial models, and resilient supply strategies will be best positioned to capture value and improve patient outcomes. As the landscape evolves, continuous engagement with clinicians, proactive investment in post-market evidence, and adaptive commercial planning will remain essential to sustaining momentum and translating innovation into routine practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence and deep learning for improved biopsy targeting accuracy and efficiency
  • 5.2. Adoption of minimally invasive vacuum-assisted biopsy systems for enhanced patient comfort and reduced procedure times
  • 5.3. Growing use of contrast-enhanced digital breast tomosynthesis guided biopsies to improve lesion visualization and sampling precision
  • 5.4. Emergence of liquid biopsy techniques complementing tissue sampling for comprehensive molecular profiling and early detection
  • 5.5. Development of portable point-of-care breast biopsy devices enabling decentralized diagnostics and faster clinical decision making
  • 5.6. Implementation of real-time ex vivo confocal microscopy to provide immediate tissue assessment and reduce repeat biopsy rates
  • 5.7. Expansion of robotic-assisted breast biopsy platforms to increase procedural consistency and limit operator variability
  • 5.8. Evolving reimbursement policies and regulatory frameworks driving adoption rates of advanced breast biopsy technologies globally

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Breast Biopsy Market, by Technology

  • 8.1. Core Needle Biopsy Devices
    • 8.1.1. Automated Core Needle Biopsy Devices
    • 8.1.2. Semi-Automated Core Needle Biopsy Devices
  • 8.2. Fine Needle Aspiration Needles
    • 8.2.1. Echo Enhanced FNA Needles
    • 8.2.2. Standard FNA Needles
  • 8.3. Vacuum-Assisted Systems
    • 8.3.1. Handheld Vacuum-Assisted
    • 8.3.2. Table Configured Vacuum-Assisted

9. Breast Biopsy Market, by Procedure Type

  • 9.1. MRI Guided
    • 9.1.1. Closed Bore
    • 9.1.2. Open Bore
  • 9.2. Palpation Guided
    • 9.2.1. Freehand Palpation
    • 9.2.2. Grid Guided
  • 9.3. Stereotactic
    • 9.3.1. Prone Stereotactic
    • 9.3.2. Upright Stereotactic
  • 9.4. Ultrasound Guided
    • 9.4.1. 2D Ultrasound Guided
    • 9.4.2. 3D Ultrasound Guided

10. Breast Biopsy Market, by End User

  • 10.1. Ambulatory Surgery Centers
    • 10.1.1. Diagnostic Centers
    • 10.1.2. Outpatient Surgery Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals
  • 10.3. Specialty Clinics
    • 10.3.1. Oncology Clinics
    • 10.3.2. Radiology Clinics

11. Breast Biopsy Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Breast Biopsy Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Breast Biopsy Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Hologic, Inc.
    • 14.3.2. Becton Dickinson and Company
    • 14.3.3. General Electric Company
    • 14.3.4. Siemens Healthineers AG
    • 14.3.5. Koninklijke Philips N.V.
    • 14.3.6. Canon Medical Systems Corporation
    • 14.3.7. Cook Medical, Inc.
    • 14.3.8. Merit Medical Systems, Inc.
    • 14.3.9. Cardinal Health, Inc.
    • 14.3.10. Medtronic plc

LIST OF FIGURES

  • FIGURE 1. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BREAST BIOPSY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS BREAST BIOPSY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL BREAST BIOPSY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BREAST BIOPSY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. BREAST BIOPSY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BREAST BIOPSY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BREAST BIOPSY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BREAST BIOPSY MARKET SIZE, BY AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BREAST BIOPSY MARKET SIZE, BY AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BREAST BIOPSY MARKET SIZE, BY AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BREAST BIOPSY MARKET SIZE, BY AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BREAST BIOPSY MARKET SIZE, BY AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BREAST BIOPSY MARKET SIZE, BY AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BREAST BIOPSY MARKET SIZE, BY SEMI-AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BREAST BIOPSY MARKET SIZE, BY SEMI-AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BREAST BIOPSY MARKET SIZE, BY SEMI-AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BREAST BIOPSY MARKET SIZE, BY SEMI-AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BREAST BIOPSY MARKET SIZE, BY SEMI-AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BREAST BIOPSY MARKET SIZE, BY SEMI-AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BREAST BIOPSY MARKET SIZE, BY ECHO ENHANCED FNA NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BREAST BIOPSY MARKET SIZE, BY ECHO ENHANCED FNA NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BREAST BIOPSY MARKET SIZE, BY ECHO ENHANCED FNA NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BREAST BIOPSY MARKET SIZE, BY ECHO ENHANCED FNA NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BREAST BIOPSY MARKET SIZE, BY ECHO ENHANCED FNA NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BREAST BIOPSY MARKET SIZE, BY ECHO ENHANCED FNA NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BREAST BIOPSY MARKET SIZE, BY STANDARD FNA NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BREAST BIOPSY MARKET SIZE, BY STANDARD FNA NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BREAST BIOPSY MARKET SIZE, BY STANDARD FNA NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BREAST BIOPSY MARKET SIZE, BY STANDARD FNA NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BREAST BIOPSY MARKET SIZE, BY STANDARD FNA NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BREAST BIOPSY MARKET SIZE, BY STANDARD FNA NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BREAST BIOPSY MARKET SIZE, BY HANDHELD VACUUM-ASSISTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BREAST BIOPSY MARKET SIZE, BY HANDHELD VACUUM-ASSISTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BREAST BIOPSY MARKET SIZE, BY HANDHELD VACUUM-ASSISTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BREAST BIOPSY MARKET SIZE, BY HANDHELD VACUUM-ASSISTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BREAST BIOPSY MARKET SIZE, BY HANDHELD VACUUM-ASSISTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BREAST BIOPSY MARKET SIZE, BY HANDHELD VACUUM-ASSISTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BREAST BIOPSY MARKET SIZE, BY TABLE CONFIGURED VACUUM-ASSISTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BREAST BIOPSY MARKET SIZE, BY TABLE CONFIGURED VACUUM-ASSISTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BREAST BIOPSY MARKET SIZE, BY TABLE CONFIGURED VACUUM-ASSISTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BREAST BIOPSY MARKET SIZE, BY TABLE CONFIGURED VACUUM-ASSISTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BREAST BIOPSY MARKET SIZE, BY TABLE CONFIGURED VACUUM-ASSISTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BREAST BIOPSY MARKET SIZE, BY TABLE CONFIGURED VACUUM-ASSISTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BREAST BIOPSY MARKET SIZE, BY CLOSED BORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BREAST BIOPSY MARKET SIZE, BY CLOSED BORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BREAST BIOPSY MARKET SIZE, BY CLOSED BORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BREAST BIOPSY MARKET SIZE, BY CLOSED BORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BREAST BIOPSY MARKET SIZE, BY CLOSED BORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BREAST BIOPSY MARKET SIZE, BY CLOSED BORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN BORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN BORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN BORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN BORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN BORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN BORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BREAST BIOPSY MARKET SIZE, BY FREEHAND PALPATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BREAST BIOPSY MARKET SIZE, BY FREEHAND PALPATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BREAST BIOPSY MARKET SIZE, BY FREEHAND PALPATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BREAST BIOPSY MARKET SIZE, BY FREEHAND PALPATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BREAST BIOPSY MARKET SIZE, BY FREEHAND PALPATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BREAST BIOPSY MARKET SIZE, BY FREEHAND PALPATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BREAST BIOPSY MARKET SIZE, BY GRID GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BREAST BIOPSY MARKET SIZE, BY GRID GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BREAST BIOPSY MARKET SIZE, BY GRID GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BREAST BIOPSY MARKET SIZE, BY GRID GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BREAST BIOPSY MARKET SIZE, BY GRID GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BREAST BIOPSY MARKET SIZE, BY GRID GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRONE STEREOTACTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRONE STEREOTACTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRONE STEREOTACTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRONE STEREOTACTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRONE STEREOTACTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRONE STEREOTACTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BREAST BIOPSY MARKET SIZE, BY UPRIGHT STEREOTACTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BREAST BIOPSY MARKET SIZE, BY UPRIGHT STEREOTACTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BREAST BIOPSY MARKET SIZE, BY UPRIGHT STEREOTACTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BREAST BIOPSY MARKET SIZE, BY UPRIGHT STEREOTACTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BREAST BIOPSY MARKET SIZE, BY UPRIGHT STEREOTACTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BREAST BIOPSY MARKET SIZE, BY UPRIGHT STEREOTACTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BREAST BIOPSY MARKET SIZE, BY 2D ULTRASOUND GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BREAST BIOPSY MARKET SIZE, BY 2D ULTRASOUND GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BREAST BIOPSY MARKET SIZE, BY 2D ULTRASOUND GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BREAST BIOPSY MARKET SIZE, BY 2D ULTRASOUND GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BREAST BIOPSY MARKET SIZE, BY 2D ULTRASOUND GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BREAST BIOPSY MARKET SIZE, BY 2D ULTRASOUND GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BREAST BIOPSY MARKET SIZE, BY 3D ULTRASOUND GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BREAST BIOPSY MARKET SIZE, BY 3D ULTRASOUND GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BREAST BIOPSY MARKET SIZE, BY 3D ULTRASOUND GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BREAST BIOPSY MARKET SIZE, BY 3D ULTRASOUND GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BREAST BIOPSY MARKET SIZE, BY 3D ULTRASOUND GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BREAST BIOPSY MARKET SIZE, BY 3D ULTRASOUND GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BREAST BIOPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BREAST BIOPSY MARKET SIZE, BY OUTPATIENT SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BREAST BIOPSY MARKET SIZE, BY OUTPATIENT SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BREAST BIOPSY MARKET SIZE, BY OUTPATIENT SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BREAST BIOPSY MARKET SIZE, BY OUTPATIENT SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BREAST BIOPSY MARKET SIZE, BY OUTPATIENT SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BREAST BIOPSY MARKET SIZE, BY OUTPATIENT SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BREAST BIOPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BREAST BIOPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BREAST BIOPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BREAST BIOPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BREAST BIOPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BREAST BIOPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BREAST BIOPSY MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BREAST BIOPSY MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BREAST BIOPSY MARKET SIZE, BY ONCOLOGY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BREAST BIOPSY MARKET SIZE, BY ONCOLOGY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BREAST BIOPSY MARKET SIZE, BY ONCOLOGY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BREAST BIOPSY MARKET SIZE, BY ONCOLOGY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BREAST BIOPSY MARKET SIZE, BY RADIOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BREAST BIOPSY MARKET SIZE, BY RADIOLOGY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BREAST BIOPSY MARKET SIZE, BY RADIOLOGY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BREAST BIOPSY MARKET SIZE, BY RADIOLOGY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BREAST BIOPSY MARKET SIZE, BY RADIOLOGY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BREAST BIOPSY MARKET SIZE, BY RADIOLOGY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS BREAST BIOPSY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS BREAST BIOPSY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS BREAST BIOPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPE BREAST BIOPSY MARK